NIH

February 9, 2017

New grants bolster Trauma program’s research initiatives

Vanderbilt University Medical Center’s Division of Trauma, Emergency General Surgery and Surgical Critical Care was recently awarded two new research grants.

By VUMC News and Communications
February 9, 2017

Team isolates new antibodies that may aid RSV vaccine design

Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide.

By Bill Snyder
February 8, 2017

Pathology of septic shock

The signaling molecule IL-15 promotes septic shock, a life-threatening condition involving organ injury caused by infection.

By Leigh MacMillan
February 7, 2017

Dementia linked to diet

Some memory deficits observed in Alzheimer’s disease may be due to co-morbid illnesses – not the disease itself – and may be reversed by lifestyle changes or pharmacologic interventions.

By VUMC News and Communications
bacteria microbiome
February 3, 2017

Bacterial signaling systems

Vanderbilt researchers have identified a unique example of communication between bacterial signaling systems, which may have relevance for antibiotic resistance.

By Leigh MacMillan
February 2, 2017

New target for chronic infection

An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.

By VUMC News and Communications
February 2, 2017

Gene mutation discovery may hold autism clues: study

Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII.
By Bill Snyder
January 26, 2017

Global health meet explores future needs

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future.
By Bill Snyder
January 25, 2017

Flu vaccine response in older adults

High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.
By Leigh MacMillan
January 24, 2017

Saliva test for obesity risk

“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.
By Bill Snyder
January 20, 2017

Improving vaccine formulations

The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.
By Sanjay Mishra
January 19, 2017

Colorectal cancer clues

Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways.
By Leigh MacMillan
January 19, 2017

Digestive Disease Research Center lands major grant

The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.
By Jill Clendening